FindTrial
Sign In

Comparison of effects of Dexmeditomidine versus Magnesium Sulphate as an adjuvant to Bupivacaine on post operative pain

Comparison of effects of port site infiltration with Dexmeditomidine versus Magnesium Sulphate as an adjuvant to Bupivacaine on post operative pain in Laproscopic Cholecystectomy - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/058808
Enrollment
66
Registered
2023-10-18
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: port site infiltration of drugs: drugs will be infiltrated through laproscopic ports for post operative pain. In 1 group inj Bupivacaine(0.5%) 75mg and inj Dexmedetomidine 50mcg would b

Sponsors

School of Medical Sciences and Research and Sharda Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients scheduled for elective laparoscopic cholecystectomy through four port under general anesthesia of ASA class 1 and 2

Exclusion criteria

Exclusion criteria: 1. Patient with history of chronic pain 2. Patient receiving steroids analgesics and sedatives 3. Patients having history of cardiovascular, endocrine, renal or CNS disease 4.Patient having history of allergy to study drug 5. BMI more then 30

Design outcomes

Primary

MeasureTime frame
To compare the time of first rescue analgesic demand(duration of postoperative analgesia)Timepoint: 24 hours—

Secondary

MeasureTime frame
To compare post operative hemodynamic parametersTimepoint: 24 hours;To compare post operative pain by VAS score in three groupsTimepoint: 24 hours;To compare the sedation score in three groupsTimepoint: 24 hours—

Countries

India

Contacts

Public ContactDr Mahendra Kumar

School of Medical Sciences and Research and Sharda Hospital

Mahendramohit@yahoo.com82878849

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026